Taysha Gene Therapies, Inc. (TSHA)

NASDAQ: TSHA · Real-Time Price · USD

5.96

-0.01 (-0.17%)

At close: Jul 17, 2026, 4:00 PM EDT

5.85

-0.11 (-1.85%)

After-hours: Jul 17, 2026, 5:35 PM EDT

Taysha Gene Therapies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	277.03	320.22	139.49	144.39	87.88	149.1
Cash & Short-Term Investments	277.03	320.22	139.49	144.39	87.88	149.1
Cash Growth	136.69%	129.57%	-3.40%	64.30%	-41.06%	-40.66%
Other Current Assets	5.23	4.43	2.65	5.48	8.54	10.5
Total Current Assets	282.25	324.65	142.13	149.87	96.42	159.6
Net Property, Plant & Equipment	15.61	16.18	15.87	20.41	25.91	50.61
Other Long-Term Assets	2.5	2.5	2.37	2.46	3.95	3.74
Total Assets	300.35	343.32	160.36	172.73	126.28	213.96
Accounts Payable	4.56	6.28	3.59	6.37	10.95	21.76
Accrued Expenses	15.53	20.28	12.86	12.28	18.29	29.98
Unearned Revenue	-	-	9.77	18.11	33.56	-
Total Current Liabilities	20.1	26.55	26.23	36.76	62.79	51.75
Long-Term Debt	48.96	50.11	43.94	40.51	37.97	37.19
Long-Term Leases	17.77	18.17	17.36	18.95	20.44	25.9
Other Long-Term Liabilities	1.58	1.55	1.31	1.58	4.13	3.74
Total Long-Term Liabilities	68.31	69.83	62.61	61.04	62.54	66.83
Total Liabilities	88.41	96.38	88.84	97.79	125.33	118.57
Common Stock	0	0	0	0	0	-
Additional Paid-in Capital	964.67	958.43	677.86	587.94	402.39	331.03
Accumulated Other Comprehensive Income	0.99	-0.19	-4.03	-	-	-
Retained Earnings	-753.71	-711.3	-602.31	-513.01	-401.44	-235.65
Shareholders' Equity	211.94	246.94	71.53	74.94	0.95	95.38
Total Liabilities & Equity	300.35	343.32	160.36	172.73	126.28	213.96
Total Debt	66.73	68.28	61.3	59.46	58.41	63.09
Net Cash (Debt)	210.3	251.94	78.18	84.93	29.47	86.01
Net Cash Growth	-16.53%	222.25%	-7.94%	188.16%	-65.73%	-65.77%
Net Cash Per Share	0.61	0.79	0.31	0.73	0.67	2.28
Book Value	211.94	246.94	71.53	74.94	0.95	95.38
Book Value Per Share	0.62	0.77	0.29	0.65	0.02	2.53
Tangible Book Value	211.94	246.94	71.53	74.94	0.95	95.38
Tangible Book Value Per Share	0.62	0.77	0.29	0.65	0.02	2.53

SEC Filings: 10-K · 10-Q